600216:SSEZhejiang Medicine Co., Ltd. Class A Analysis
Data as of 2026-09-16 - not real-time
CN¥12.49
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Zhejiang Medicine Co., Ltd. is neutral at ¥12.49, with no clear ordering between short and long averages. The last 30 days have gained 2.5%. With RSI at 45.4 the momentum picture is neutral, alongside a bearish MACD signal. Watch ¥12.15 as support and ¥14.53 as the nearer resistance level.
The shares look undervalued, trading on 14.9 times earnings below a sector average of 30.0. Consensus targets land 38.1% above where the shares trade now. Revenue is growing at 6.2% on a 9.0% profit margin. The 2.24% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 50.5%, a beta of 0.03 and a maximum drawdown of 38.6%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
The shares look undervalued, trading on 14.9 times earnings below a sector average of 30.0. Consensus targets land 38.1% above where the shares trade now. Revenue is growing at 6.2% on a 9.0% profit margin. The 2.24% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 50.5%, a beta of 0.03 and a maximum drawdown of 38.6%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
Top Market Events
Latest Zhejiang Medicine Co Ltd 600216:SHH.Latest Zhejiang Medicine Co Ltd 600216:SHH.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading below the 200-day average of 13.90
- MACD momentum is negative
- 30-day volatility of 50.5%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 14.9 versus sector average of 30.0
- Trading below the 200-day average of 13.90
- Analyst targets imply +38.1% versus the current price
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 14.9 versus sector average of 30.0
- Analyst targets imply +38.1% versus the current price
- 30-day volatility of 50.5%
Key Metrics & Analysis
Financial Health
Revenue Growth6.20%
Profit Margin9.01%
P/E Ratio14.9
ROE5.54%
ROA3.60%
Debt/Equity7.60
P/B Ratio1.0
Op. Cash FlowCN¥1.5B
Free Cash FlowCN¥979.9M
Industry P/E30.0
Technical Analysis
TrendNeutral
RSI45.4
SupportCN¥12.15
ResistanceCN¥14.53
MA 20CN¥12.94
MA 50CN¥12.59
MA 200CN¥13.90
MACDBearish
VolumeDecreasing
Fear & Greed Index90.71
Valuation
Fair ValueCN¥19.55
Target PriceCN¥17.25
Upside/Downside38.11%
GradeUndervalued
TypeValue
Dividend Yield2.24%
Risk Assessment
Beta0.03
Volatility50.51%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.